ATE412423T1 - Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion - Google Patents

Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Info

Publication number
ATE412423T1
ATE412423T1 AT02731136T AT02731136T ATE412423T1 AT E412423 T1 ATE412423 T1 AT E412423T1 AT 02731136 T AT02731136 T AT 02731136T AT 02731136 T AT02731136 T AT 02731136T AT E412423 T1 ATE412423 T1 AT E412423T1
Authority
AT
Austria
Prior art keywords
infection
peroxiredoxin
drugs
treating hiv
hiv
Prior art date
Application number
AT02731136T
Other languages
English (en)
Inventor
Ralf Lynn
Bruce Walker
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE412423T1 publication Critical patent/ATE412423T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01015—Peroxiredoxin (1.11.1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02731136T 2001-03-23 2002-03-18 Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion ATE412423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27823401P 2001-03-23 2001-03-23
US10/057,593 US20020168353A1 (en) 2001-03-23 2002-01-25 Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE412423T1 true ATE412423T1 (de) 2008-11-15

Family

ID=26736676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731136T ATE412423T1 (de) 2001-03-23 2002-03-18 Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Country Status (5)

Country Link
US (3) US20020168353A1 (de)
EP (1) EP1370697B1 (de)
AT (1) ATE412423T1 (de)
DE (1) DE60229624D1 (de)
WO (1) WO2002077294A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2505478A1 (en) * 2002-11-10 2004-05-27 Institute Of Cell Biophysics Russian Academy Of Sciences Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
KR100610774B1 (ko) * 2005-02-03 2006-08-28 이화여자대학교 산학협력단 퍼록시레독신 2 단백질을 유효성분으로 함유하는 혈관재협착 예방 및 치료용 약학조성물, 퍼록시레독신 2유전자 또는 그로부터 발현되는 단백질을 포함하는 혈관재협착 치료제 스크리닝용 조성물 및 이를 이용하는 혈관재협착 치료제 스크리닝 방법
US9050291B2 (en) * 2009-12-08 2015-06-09 Health Research Inc. Methods and compositions using peroxiredoxin 1 (PRX1) as an adjuvant
US20110177091A1 (en) * 2009-12-08 2011-07-21 Gollnick Sandra O Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
US5610286A (en) * 1991-11-04 1997-03-11 The Regents Of The University Of California DNA's encoding natural killer cell enhancing factor
WO1996039424A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Natural killer cell enhancing factor c
US6150135A (en) * 1997-05-23 2000-11-21 Heska Corporation Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof

Also Published As

Publication number Publication date
EP1370697A4 (de) 2004-04-14
US20060099199A1 (en) 2006-05-11
DE60229624D1 (de) 2008-12-11
US20090246821A1 (en) 2009-10-01
EP1370697B1 (de) 2008-10-29
US20020168353A1 (en) 2002-11-14
WO2002077294A1 (en) 2002-10-03
EP1370697A1 (de) 2003-12-17

Similar Documents

Publication Publication Date Title
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
ATE377657T1 (de) Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
NO20034056D0 (no) Proliferative sykdommer
BG66080B1 (bg) Заместени тиоацетамиди
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
SE0302304D0 (sv) Novel compounds
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
ATE253936T1 (de) Glutathion-reduktase zur behandlung und prophylaxe von aids
DE60331654D1 (de) Nicht-radioaktives Strontiummittel zur Behandlung von Krebs
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
DE60118363D1 (de) Methoden zur behandlung des kryptorchysmus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties